Effects of a Digitally Supported Physical Activity Intervention in Knee Osteoarthritis: A Pilot Randomized Controlled Trial

数字化支持的身体活动干预对膝骨关节炎的影响:一项试点随机对照试验

阅读:1

Abstract

OBJECTIVES: The aim of this study was to investigate the effects of a digitally supported physical activity (PA) intervention on pain, physical function, exercise adherence and quality of life in females with knee osteoarthritis (OA). METHODS: Thirty female participants with knee OA were randomly assigned to either a control group (n = 15) receiving patient education, smartwatch use, and a home exercise programme, or an intervention group (n = 15) receiving an additional digitally supported walking programme. The primary outcome measures were pain severity (Numerical Pain Rating Scale [NPRS]), physical function (Western Ontario and McMaster Universities Arthritis Index [WOMAC]) and exercise adherence. Secondary outcomes included quality of life (European Quality of Life Scale 5 Dimensions/EQ-5D-3L), daily step count and pain catastrophizing (Pain Catastrophizing Scale/PCS). Assessments were performed at baseline and after 8 weeks. RESULTS: The intervention group showed significantly greater improvements in pain severity (1.4 cm larger improvement on NPRS; p = 0.005), physical function (6.4-point larger improvement on WOMAC total score; p = 0.003) and daily step count (1548 steps larger improvement; p = 0.045) compared to the control group. Both groups demonstrated similar significant improvements in exercise adherence, pain catastrophizing, and quality of life (p < 0.05). CONCLUSIONS: A digitally supported PA intervention, in addition to patient education and a home exercise programme, significantly improved pain, physical function and PA in females with knee OA. These findings support the efficacy of structured, supervised digital interventions for enhancing outcomes in this population. Future studies should explore strategies to enhance long-term adherence through digital PA interventions. TRIAL REGISTRATION: This study was conducted in compliance with the Declaration of Helsinki (Clinical Trial Registry Number: NCT05810376).

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。